Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Lung Cancer. 2021 Apr 18;156:68–71. doi: 10.1016/j.lungcan.2021.04.016

Table 1.

Select Patient and Treatment Characteristics

Arm B (N=70) Arm C (N=70) Total (N=140) p value
Weight Loss 6 Months Prior to Study 0.5316
 <=5% / 6 months 57 (81.4%) 54 (77.1%) 111 (79.3%)
 >5% / 6 months 13 (18.6%) 16 (22.9%) 29 (20.7%)
Performance Status 0.7957
 0 30 (42.9%) 30 (42.9%) 60 (42.9%)
 1 34 (48.6%) 36 (51.4%) 70 (50.0%)
 2 6 (8.6%) 4 (5.7%) 10 (7.1%)
Radiotherapy Method 1.0000
 IMRT 21 (30.0%) 21 (30.0%) 42 (30.0%)
 3D 49 (70.0%) 49 (70.0%) 98 (70.0%)
RT Start Time 0.5740
 Cycle 1 49 (70.0%) 50 (71.4%) 99 (70.7%)
 Cycle 2 21 (30.0%) 20 (28.5%) 40 (28.6%)

RT, radiotherapy